Posts by Sandra Ansanay-Alex
CSEM Inventor Award granted to spaceCoder
Shedding Light on Precision: CSEM spaceCoder technology is a game changer in the field of precision measurement In the realm of scientific innovation, where light illuminates, shadows also cast opportunities for advancement. Researchers at CSEM (Centre Suisse d’Electronique et de Microtechnique) have ingeniously harnessed this principle with their groundbreaking “spaceCoder” technology, heralding a…
Read MoreSuccessful € 5 Million Capital Increase for GeNeuro
GeNeuro, a Geneva-based biopharmaceutical company focusing on treatments for neurodegenerative and autoimmune diseases, including multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), and severe neuropsychiatric consequences of COVID-19 (post-COVID), has successfully completed a €5 million capital increase. The increase involved a private placement of 4,666,901 new GeNeuro ordinary bearer shares for specialized and strategic…
Read MoreNicolas Durand appointed Director of the Campus Biotech Foundation in Geneva
Dr Nicolas Durand will step down from his CEO role at Abionic on 29 February to be at the steering wheel of the innovation centre from 1 March 2024 The Foundation Campus Biotech announced the appointment of its new Director, Dr Nicolas Durand. “With an extensive background in nanotechnologies applied to life sciences,…
Read MoreDebiopharm and TransCode Therapeutics Collaborate to Develop Targeted Nucleic Acid Therapeutics for Cancer
TransCode Therapeutics is a RNA oncology company based in the United States committed to more effectively treating cancer using RNA therapeutics. Debiopharm, a privately-owned Swiss-based, global biopharmaceutical company, aims to establish tomorrow’s standard-of-care to cure cancer and infectious diseases. The collaboration will explore combining TransCode’s proprietary TTX delivery platform with Debiopharm’s expertise in…
Read MoreVaud: a CHF 90 Million plan to tackle the shortage of healthcare staff
The Vaud State Council has drawn up a CHF 90 Million “far-reaching plan” to meet the challenges presented by the shortage of healthcare and nursing staff: the InvestPro programme will be based on training, promotion of the professions in the field and retention. Demographic change, an ageing population and an increase in chronic…
Read MoreTransmutex raises CHF 20 Million
The Geneva-based company, founded in 2019, has secured new funding to further develop its research into safer, cleaner and cheaper nuclear power generation. The technology could also have healthcare applications. Geneva-based nuclear engineering company Transmutex has secured CHF 20 Million in financing from New York-based venture capital funds Union Square Ventures and Steel…
Read MorePfizer Research Prize: 3 Researchers From The Swiss Health Valley Awarded
13 young researchers from Fribourg, Geneva, Basel, Bern, and Zurich have won a 2024 Pfizer Research Award. Since 1992, Pfizer Prize for Research has been awarded annually to young scientists conducting research at Swiss research institutes or hospitals. The award, is aimed at outstanding and pioneering contributions in pure and clinical research. Each awarded…
Read MoreThe Roger de Spoelberch Prize Awarded to a UNIGE Researcher
Professor Denis Jabaudon, Director of the Department of Basic Neuroscience and member of the Synapsy Center for Neuroscience Research in Mental Health (Faculty of Medicine), has won the Roger de Spoelberch Prize 2023 for his research into brain development. A specialist in the formation of cortical networks, Prof. Denis Jabaudon is also the…
Read MoreLonza Achieves Strong Financial Results in 2023 Amid Leadership Transition
The Swiss CDMO announces robust sales of CHF 6.7 billion, delivering 10.9%1 CER sales growth, and the nomination of Jean-Marc Huët to succeed Albert M. Baehny as chairman of the company. Lonza, a leading CDMO (Contract Development and Manufacturing Organization), has reported robust financial results for the year 2023. The company achieved sales…
Read MoreStämm chooses Valais to set up its European team
The Argentinian biomanufacturing innovator is launching its R&D facility at the BioArk in Monthey Founded in 2016 in Argentina, Stämm, now boasting a robust team of over 200 in Buenos Aires and San Francisco, specializes in harnessing nature-inspired, data-driven solutions to revolutionize bioprocessing. With the establishment of its new R&D facility in Western…
Read More